|
1
|
Roth GA, Huffman MD, Moran AE, Feigin V,
Mensah GA, Naghavi M and Murray CJ: Global and regional patterns in
cardiovascular mortality from 1990 to 2013. Circulation.
132:1667–1678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Whelan RS, Kaplinskiy V and Kitsis RN:
Cell death in the pathogenesis of heart disease: Mechanisms and
significance. Annu Rev Physiol. 72:19–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv
F, Liu Y, Zheng W, Shang H, Zhang J, et al: CaMKII is a RIP3
substrate mediating ischemia- and oxidative stress-induced
myocardial necroptosis. Nat Med. 22:175–182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Messadi-Laribi E, Griol-Charhbili V, Gaies
E, Vincent MP, Heudes D, Meneton P, Alhenc-Gelas F and Richer C:
Cardioprotection and kallikrein-kinin system in acute myocardial
ischaemia in mice. Clin Exp Pharmacol Physio. 35:489–493. 2008.
View Article : Google Scholar
|
|
5
|
Investigators S, Yusuf S, Pitt B, Davis
CE, Hood WB and Cohn JN: Effect of enalapril on survival in
patients with reduced left ventricular ejection fractions and
congestive heart failure. N Engl J Med. 325:293–302. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Investigators S, Yusuf S, Pitt B, Davis
CE, Hood WB Jr and Cohn JN: Effect of enalapril on mortality and
the development of heart failure in asymptomatic patients with
reduced left ventricular ejection fractions. N Engl J Med.
327:685–691. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yusuf S, Pepine CJ, Garces C, Pouleur H,
Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M and Pitt B:
Effect of enalapril on myocardial infarction and unstable angina in
patients with low ejection fractions. Lancet. 340:1173–1178. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Szummer K, Wallentin L, Lindhagen L,
Alfredsson J, Erlinge D, Held C, James S, Kellerth T, Lindahl B,
Ravn-Fischer A, et al: Improved outcomes in patients with
ST-elevation myocardial infarction during the last 20 years are
related to implementation of evidence-based treatments: Experiences
from the swedeheart registry 1995–2014. Eur Heart J. 38:3056–3065.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Velez Rueda JO, Palomeque J and Mattiazzi
A: Early apoptosis in different models of cardiac hypertrophy
induced by high renin-angiotensin system activity involves CaMKII.
J Appl Physiol (1985). 112:2110–2120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang M, Wei X, Guo Y, Breslin P, Zhang S,
Zhang S, Wei W, Xia Z, Diaz M, Akira S and Zhang J: TAK1 is
required for the survival of hematopoietic cells and hepatocytes in
mice. J Exp Med. 205:1611–1619. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sakurai H: Targeting of TAK1 in
inflammatory disorders and cancer. Trends Pharmacol Sci.
33:522–530. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Buglio D, Palakurthi S, Byth K, Vega F,
Toader D, Saeh J, Neelapu SS and Younes A: Essential role of TAK1
in regulating mantle cell lymphoma survival. Blood. 120:347–355.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schuman J, Chen Y, Podd A, Yu M, Liu HH,
Wen R, Chen ZJ and Wang D: A critical role of TAK1 in B-cell
receptor-mediated nuclear factor kappaB activation. Blood.
113:4566–4574. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao Y, Li H and Zhang J, Volk A, Zhang S,
Wei W, Zhang S, Breslin P and Zhang J: TNF-α/Fas-RIP-1-induced cell
death signaling separates murine hematopoietic stem
cells/progenitors into 2 distinct populations. Blood.
118:6057–6067. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De Windt LJ, Lim HW, Taigen T, Wencker D,
Condorelli G, Dorn GW 2nd, Kitsis RN and Molkentin JD:
Calcineurin-mediated hypertrophy protects cardiomyocytes from
apoptosis in vitro and in vivo an apoptosis-independent model of
dilated heart failure. Circ Res. 86:255–263. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vashishta A, Habas A, Pruunsild P, Zheng
JJ, Timmusk T and Hetman M: Nuclear factor of activated T-cells
isoform c4 (NFATc4/NFAT3) as a mediator of antiapoptotic
transcription in NMDA receptor-stimulated cortical neurons. J
Neurosci. 29:15331–15340. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stokes WS: Best practices for the use of
animals in toxicological research and testing. Ann N Y Acad Sci.
1245:17–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fink D, Romanowski K, Valuckaite V,
Babrowski T, Kim M, Matthews JB, Liu D, Zaborina O and Alverdy JC:
Pseudomonas aeruginosa potentiates the lethal effect of intestinal
ischemia-reperfusion injury: The role of in vivo virulence
activation. J Trauma. 71:1575–1582. 2011.PubMed/NCBI
|
|
19
|
Liu YH, Xu J, Yang XP, Yang F, Shesely E
and Carretero OA: Effect of ACE inhibitors and angiotensin II type
1 receptor antagonists on endothelial no synthase knockout mice
with heart failure. Hypertension. 39:375–381. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leuschner F, Panizzi P, Chico-Calero I,
Lee WW, Ueno T, Cortez-Retamozo V, Waterman P, Gorbatov R,
Marinelli B, Iwamoto Y, et al: Angiotensin-converting enzyme
inhibition prevents the release of monocytes from their splenic
reservoir in mice with myocardial infarction. Circ Res.
107:1364–1373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tanaka M, Suemaru K, Watanabe S, Cui R, Li
B and Araki H: Comparison of short- and long-acting
benzodiazepine-receptor agonists with different receptor
selectivity on motor coordination and muscle relaxation following
thiopental-induced anesthesia in mice. J Pharmacol Sci.
107:277–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li L, Chen Y, Doan J, Murray J, Molkentin
JD and Liu Q: Transforming growth factor beta-activated kinase 1
signaling pathway critically regulates myocardial survival and
remodeling. Circulation. 130:2162–2172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Erickson JR, Joiner ML, Guan X, Kutschke
W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O'Donnell SE,
Aykin-Burns N, et al: A dynamic pathway for calcium-independent
activation of CaMKII by methionine oxidation. Cell. 133:462–474.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He BJ, Joiner ML, Singh MV, Luczak ED,
Swaminathan PD, Koval OM, Kutschke W, Allamargot C, Yang J, Guan X,
et al: Oxidation of CaMKII determines the cardiotoxic effects of
aldosterone. Nat Med. 17:1610–1618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakamura H, Umemoto S, Naik G, Moe G,
Takata S, Liu P and Matsuzaki M: Induction of left ventricular
remodeling and dysfunction in the recipient heart after donor heart
myocardial infarction. J Am College Cardiol. 42:173–181. 2003.
View Article : Google Scholar
|
|
26
|
Jugdutt BI, Menon V, Kumar D and Idikio H:
Vascular remodeling during healing after myocardial infarction in
the dog model: Effects of reperfusion, amlodipine and enalapril. J
Am Coll Cardiol. 39:1538–1545. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamaguchi K, Shirakabe K, Shibuya H, Irie
K, Oishi I, Ueno N, Taniguchi T, Nishida E and Matsumoto K:
Identification of a member of the MAPKKK family as a potential
mediator of TGF-beta signal transduction. Science. 270:2008–2011.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsumoto-Ida M, Takimoto Y, Aoyama T,
Akao M, Takeda T and Kita T: Activation of TGF-beta1-TAK1-p38 MAPK
pathway in spared cardiomyocytes is involved in left ventricular
remodeling after myocardial infarction in rats. Am J Physiol Heart
Circ Physiol. 290:H709–H715. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aonuma T, Takehara N, Maruyama K, Kabara
M, Matsuki M, Yamauchi A, Kawabe J and Hasebe N:
Apoptosis-resistant cardiac progenitor cells modified with
apurinic/apyrimidinic endonuclease/redox factor 1 gene
overexpression regulate cardiac repair after myocardial infarction.
Stem Cells Transl Med. 5:1067–1078. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morioka S, Inagaki M, Komatsu Y, Mishina
Y, Matsumoto K and Ninomiya-Tsuji J: TAK1 kinase signaling
regulates embryonic angiogenesis by modulating endothelial cell
survival and migration. Blood. 120:3846–3857. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mihaly SR, Ninomiya-Tsuji J and Morioka S:
TAK1 control of cell death. Cell Death Differ. 21:1667–1676. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fauster A, Rebsamen M, Huber KV, Bigenzahn
JW, Stukalov A, Lardeau CH, Scorzoni S, Bruckner M, Gridling M,
Parapatics K, et al: A cellular screen identifies ponatinib and
pazopanib as inhibitors of necroptosis. Cell Death Dis.
6:e17672015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sicard P, Jacquet S, Kobayashi KS, Flavell
RA and Marber MS: Pharmacological postconditioning effect of
muramyl dipeptide is mediated through RIP2 and TAK1. Cardiovasc
Res. 83:277–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Endale M, Kim TH, Kwak YS, Kim NM, Kim SH,
Cho JY, Yun BS and Rhee MH: Torilin inhibits inflammation by
limiting TAK1-mediated map kinase and NF-κB activation. Mediators
Inflamm. 2017:72509682017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wi SM, Moon G, Kim J, Kim ST, Shim JH,
Chun E and Lee KY: TAK1-ECSIT-TRAF6 complex plays a key role in the
TLR4 signal to activate NF-κB. J Biol Chem. 289:35205–35214. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Crabtree GR and Olson EN: NFAT signaling:
Choreographing the social lives of cells. Cell. 109:S67–S79. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Crabtree GR: Generic signals and specific
outcomes: Signaling through Ca2+, calcineurin, and NF-AT. Cell.
96:611–614. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Echtermeyer F, Harendza T, Hubrich S,
Lorenz A, Herzog C, Mueller M, Schmitz M, Grund A, Larmann J,
Stypmann J, et al: Syndecan-4 signalling inhibits apoptosis and
controls NFAT activity during myocardial damage and remodelling.
Cardiovasc Res. 92:123–131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bueno OF, Lips DJ, Kaiser RA, Wilkins BJ,
Dai YS, Glascock BJ, Klevitsky R, Hewett TE, Kimball TR, Aronow BJ,
et al: Calcineurin abeta gene targeting predisposes the myocardium
to acute ischemia-induced apoptosis and dysfunction. Circ Res.
94:91–99. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li L, Chen Y, Li J, Yin H, Guo X, Doan J,
Molkentin JD and Liu Q: TAK1 regulates myocardial response to
pathological stress via NFAT, NFkB, and Bnip3 pathways. Sci Rep.
5:166262015. View Article : Google Scholar : PubMed/NCBI
|
